Contact Us (781) 301-7474

Hemanext AABB 2021

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs). Learn More...

Connect with Hemanext at ISBT 2020

Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with...


We use cookies to understand how you use our site and to improve your experience. This includes personalizing content. To learn more, click here.